Quick Answer
ImageneBio, Inc. reported Operating Income of -$48.45 million for fiscal year 2025.
ImageneBio, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$48.45M | -30.9% |
| 2024 | -$37.00M | +50.9% |
| 2023 | -$75.42M | -6.4% |
| 2022 | -$70.90M | -107.7% |
| 2021 | -$34.14M | +23.3% |
| 2020 | -$44.52M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$26.59M | -1206.2% | -203.9% |
| June 30, 2025 | -$8.75M | +44.7% | +18.9% |
| March 31, 2025 | -$10.79M | +40.8% | -430.2% |
| September 30, 2024 | -$2.04M | +89.6% | +87.1% |
| June 30, 2024 | -$15.82M | +14.4% | +13.2% |
| March 31, 2024 | -$18.23M | -17.5% | +6.5% |
| September 30, 2023 | -$19.50M | -9.1% | -5.5% |
| June 30, 2023 | -$18.49M | +11.7% | -19.2% |
- ImageneBio, Inc. showed a decrease of -30.9% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, ImageneBio, Inc.’s operating income has declined by 8.8% (from -$44.52 million to -$48.45 million).
- The most recent figure is from ImageneBio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: